A Phase 2 to Evaluate the Efficacy, Safety and Tolerability of Combinations of Bedaquiline, Moxifloxacin, PA-824 and Pyrazinamide in Adult Subjects With Drug-Sensitive or Multi Drug-Resistant Pulmonary Tuberculosis.
Clinical trial NCT02193776 · COMPLETED
Trial details
- NCT number
- NCT02193776
- Sponsor
- Global Alliance for TB Drug Development
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-23
- Primary completion
- 2016-02-08
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.